-
1
المؤلفون: Stacie B. Dusetzina, Elizabeth J. Davis, Henry T. Quach, Jeffrey A. Sosman, Laura X. Wang, Douglas B. Johnson, Nikil V. Moodabigil
المصدر: Cancer
مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Drug-Related Side Effects and Adverse Reactions, Combination therapy, Programmed Cell Death 1 Receptor, Drug Resistance, Ipilimumab, Pembrolizumab, Antibodies, Monoclonal, Humanized, Article, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, CTLA-4 Antigen, 030212 general & internal medicine, Adverse effect, Glucocorticoids, Melanoma, Aged, Retrospective Studies, Aged, 80 and over, business.industry, Incidence (epidemiology), Middle Aged, Patient Acceptance of Health Care, medicine.disease, Progression-Free Survival, Infliximab, Nivolumab, Oncology, 030220 oncology & carcinogenesis, Disease Progression, Female, business, Follow-Up Studies, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::441069edc41d4157073d3f2cee899993Test
https://doi.org/10.1002/cncr.32542Test -
2
المؤلفون: Angelica Bialczak, Alexander N. Shoushtari, Daniel Y. Wang, Jeewon Chon, Ryan J. Sullivan, Meghan J. Mooradian, Cathy Yi Xia, Douglas B. Johnson, Alexander M. Menzies, Kelly Abbate, Karim R. Saab
المصدر: Cancer
مصطلحات موضوعية: Adult, Male, Proto-Oncogene Proteins B-raf, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Pyridones, Programmed Cell Death 1 Receptor, Population, Pyrimidinones, Article, Tertiary Care Centers, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Oximes, Humans, Medicine, 030212 general & internal medicine, education, Adverse effect, Melanoma, Protein Kinase Inhibitors, neoplasms, Aged, Dose Modification, Aged, 80 and over, Trametinib, education.field_of_study, business.industry, Australia, Imidazoles, Dabrafenib, Middle Aged, medicine.disease, Survival Analysis, United States, Discontinuation, Regimen, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Female, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5019125a85fa9b67884971a23cad8af5Test
https://doi.org/10.1002/cncr.31889Test -
3
المؤلفون: Niramol Savaraj, Lynn G. Feun, Stephen P. Richman, Ying-Ying Li, Deukwoo Kwon, Beatrice L. Madrazo, Peter J. Hosein, Chunjing Wu, Paul J. Martin, Patricia D. Jones, Monica T. Garcia-Buitrago, Medhi Wangpaichitr
المصدر: Cancer
مصطلحات موضوعية: Sorafenib, Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Carcinoma, Hepatocellular, Programmed Cell Death 1 Receptor, Phases of clinical research, Pembrolizumab, Kaplan-Meier Estimate, Antibodies, Monoclonal, Humanized, B7-H1 Antigen, Article, 03 medical and health sciences, Interferon-gamma, 0302 clinical medicine, Transforming Growth Factor beta, Internal medicine, Blood plasma, medicine, Humans, 030212 general & internal medicine, Prospective Studies, Adverse effect, Aged, Hepatitis, Aged, 80 and over, business.industry, Liver Neoplasms, Middle Aged, medicine.disease, Progression-Free Survival, Interleukin-10, Gene Expression Regulation, Neoplastic, Treatment Outcome, 030220 oncology & carcinogenesis, Hepatocellular carcinoma, Toxicity, Disease Progression, Female, business, medicine.drug, Tomography, Emission-Computed
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89eb94a0ab4712d67c8ba39e030868aaTest
https://pubmed.ncbi.nlm.nih.gov/31251403Test